Seraxis Inc.
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Drug Discovery Technologies
- Medical Devices
- Pharmaceuticals
Other Names/Subsidiaries
- Seraxis, Pte. Ltd.
Latest on Seraxis Inc.
Vertex remains bullish on prospects for developing curative, endogenous insulin-sparing cell therapies for type 1 diabetes, despite disappointing results unveiled on 28 March that led the Boston-based
Halfway through February, seven different sources of funding for health care and life science innovations have announced newly raised pools of cash totaling $2.2bn for a wide array of technologies, in
Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. OncoSec
IN VITRO DIAGNOSTICS Asuragen Inc. Series D round brings $15mm to Asuragen Asuragen Inc. (mRNA- and miRNA-based molecular diagnostics for cancer and genetic diseases) raised $15mm from 15 undi